Efficacy and safety of Androgen Deprivation Therapy (ADT) combined with modified docetaxel chemotherapy versus ADT combined with standard docetaxel chemotherapy in patients with metastatic castration-resistant prostate cancer: study protocol for a multicentre prospective randomized controlled trial

Peer Review reports

Original Submission
22 Oct 2021	Submitted	Original manuscript
7 Feb 2022	Author responded	Author comments - Xiangwei Yang
Resubmission - Version 2
7 Feb 2022	Submitted	Manuscript version 2
Publishing
8 Feb 2022	Editorially accepted
16 Feb 2022	Article published	10.1186/s12885-022-09276-y

Back to article page